ニュース/Reuters/Sino Biopharmaceutical Says TQB2102 Included In Breakthrough Therapeutic Designation Process In ChinaSino Biopharmaceutical Says TQB2102 Included In Breakthrough Therapeutic Designation Process In ChinaRefinitiv1分未満で読めます1177Sino Biopharmaceutical Ltd 1177:TQB2102 INCLUDED IN BREAKTHROUGH THERAPEUTIC DESIGNATION PROCESS IN CHINAReutersアジア中国株香港株© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html詳細を表示ログイン、もしくは永年無料のアカウントを作成して、このニュースを読みましょう始めましょう
